Publications

5674 Results

Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes [Editorial]

Authors
T Leal;S Dahlberg;S Ramalingam
Journal / Conference
Journal of Clinical Oncology Jul;23(5):e317-e320
Year
2022
Research Committee(s)
Lung
PMID
PMID35658027
Study Number(s)
S1400, S1800A

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

Authors
P Goodwin;B Chen;K Gelmon;T Whelan;M Ennis;J Lemieux;J Ligibel;D Hershman;I Mayer;T Hobday;J Bliss;P Rastogi;M Rabaglio-Poretti;S Mukherjee;J Mackey;V Abramson;C Oja;R Wesolowski;A Thompson;D Rea;P Stos;L Shepherd;V Stambolic;W Parulekar
Journal / Conference
JAMA May 24;327(20):1963-1973
Year
2022
Research Committee(s)
Breast
PMID
PMID35608580
PMC
PMC9131745

Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Authors
L Korde;M Somerfield;D Hershman
Journal / Conference
JCO Oncology Practice May 20;40(15):1696-1698
Year
2022
Research Committee(s)
Breast
PMID
PMID35417251

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia

Authors
L Muffly;J Yin;S Jacobson;A Wall;E Quiroz;A Advani;S Luger;M Tallman;M Litzow;M Foster;F Appelbaum;H Erba;R Larson;T Keegan;W Stock
Journal / Conference
Blood Advances Jul 26;6(14):4085-4092
Year
2022
Research Committee(s)
Leukemia
PMID
PMID35838753
Study Number(s)
C10403

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)

Authors
S Lee;C Ma;S Zhang;F-S Ou;T Bainter;D Niedzwiecki;L Saltz;R Mayer;R Whittom;A Hantel;AB Benson;D Atienza;H Kindler;C Gross;M Irwin;J Meyerhardt;C Fuchs
Journal / Conference
Oncologist Jun 8;27(6):e494-e505
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID35641198
PMC
PMC9177101
Study Number(s)
C89803

Extranodal presentation in limited stage DLBCL as a prognostic marker in three SWOG trials S0014, S0313 and S1001 [Letter to Editor]

Authors
D Stephens;H Li;L Constine;T Fitzgerald;J Leonard;B Kahl;M LeBlanc;S Smith;JW Friedberg;D Persky
Journal / Conference
Haematologica Nov 1;107(11):2732-2736
Year
2022
Research Committee(s)
Lymphoma
PMID
PMID35833300
PMC
PMC9614528
Study Number(s)
S0014, S0313, S1001

Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer

Authors
E Van Blarigan;F Ou;T Bainter;C Fuchs;D Niedzwiecki;S Zhang;L Saltz;R Mayer;A Hantel;A Benson;D Atienza;M Messino;H Kindler;A Venook;S Ogino;H Sanoff;E Giovannucci;K Ng;J Meyerhardt
Journal / Conference
JAMA Network Open Feb 1;5(2):e220145. doi: 10.1001/jamanetworkopen.2022.0145
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID35191970
PMC
PMC8864503
Study Number(s)
C89803

Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314

Authors
G Dancik;D Theodorescu
Journal / Conference
European Urology Focus Mar 23;S2405-4569(22)00067-0
Year
2022
Research Committee(s)
Genitourinary
PMID
PMID35339415
Study Number(s)
S1314

Restricted survival benefit with right-censored data

Authors
S Zhang;M LeBlanc;Y Zhao
Journal / Conference
Biometrical Journal Apr;64(4):696-713
Year
2022
Research Committee(s)
Myeloma
PMID
PMID34970772
PMC
PMC9162957
Study Number(s)
S0777

Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis

Authors
N Corsi;E Messing;A Sood;J Keeley;C Bronchema;N Rakic;M Jamil;D Dalela;S Arora;A Piontkowski;S Majdalany;M Butaney;I Rakic;P Li;M Menon;C Rogers;F Abdollah
Journal / Conference
Clinical Genitourinary Cancer Jun 25;S1558-7673(22)00140-9
Year
2022
Research Committee(s)
Genitourinary
PMID
PMID35871040
Study Number(s)
S0337